TF Inhibitors, short for Transcription Factor Inhibitors, represent a pivotal class of chemical compounds that exert their influence at the core of gene regulation processes in living organisms. Transcription factors (TFs) are proteins that orchestrate gene expression by binding to specific DNA sequences, thereby either activating or repressing the transcription of target genes. TFs play a fundamental role in various biological functions, ranging from development and differentiation to response to external stimuli. TF Inhibitors are designed to modulate these intricate regulatory mechanisms by interfering with the interactions between transcription factors and DNA, thereby exerting a nuanced control over gene expression. The structural diversity of TF Inhibitors is extensive, incorporating a wide range of chemical moieties and mechanisms of action. Some compounds work by competitively binding to the DNA-binding domains of transcription factors, preventing their access to target gene promoters. Others target the protein-protein interaction interfaces of TFs, disrupting their ability to form complexes with co-activators or co-repressors. This class of inhibitors may also function by altering the conformational dynamics of transcription factors, rendering them less effective in recognizing and binding to DNA sequences. Additionally, some TF Inhibitors may act indirectly by affecting upstream signaling pathways that regulate the expression or activity of specific TFs.
Understanding the molecular details of TF Inhibitors and their mode of action has far-reaching implications in unraveling the intricacies of gene regulation networks and their relevance in physiological and pathological contexts. These inhibitors provide invaluable tools for deciphering the functional roles of individual transcription factors and their downstream targets, contributing to a deeper comprehension of intricate cellular processes. By exploiting the versatility and specificity of TF Inhibitors, researchers can uncover novel insights into the complexity of gene regulatory networks, shedding light on their involvement in diverse biological phenomena and potentially uncovering new avenues for modulating cellular behaviors in various contexts.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Binds to DNA and prevents RNA synthesis by inhibiting RNA polymerase activity. | ||||||
Flavopiridol | 146426-40-6 | sc-202157 sc-202157A | 5 mg 25 mg | $78.00 $259.00 | 41 | |
Inhibits cyclin-dependent kinases (CDKs), regulating cell cycle progression and transcription by TFs. | ||||||
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $90.00 $204.00 | 13 | |
Blocks RNA polymerase II-mediated transcription by disrupting the assembly of transcription initiation complex. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Modulates TF activity (e.g., NF-κB) by affecting signaling pathways, thus impacting gene expression and inflammation. | ||||||
Etoposide (VP-16) | 33419-42-0 | sc-3512B sc-3512 sc-3512A | 10 mg 100 mg 500 mg | $51.00 $231.00 $523.00 | 63 | |
Induces DNA damage by inhibiting topoisomerase II activity, leading to TF binding defects and altered gene expression. | ||||||